RESUMEN
This study elucidates the question of whether chronic inflammation in the jawbone contributes to the development of Chronic Fatigue Syndrome (CFS). Fatty degenerative osteonecrosis in jawbone (FDOJ) may contribute to CFS by induction of inflammatory mediators. We examined seven cytokines by multiplex analysis in jawbone samples from two groups of patients. In order to clarify neurological interrelations, specimens from 21 CFS patients were analyzed from areas of previous surgery in the retromolar wisdom tooth area. Each of the retromolar jawbone samples showed clinically fatty degenerated and osteonecrotic medullary changes. As control, healthy jawbone specimens from 19 healthy patients were analyzed. All fatty necrotic and osteolytic jawbone (FDOJ) samples showed high expression of RANTES and fibroblast growth factor (FGF)-2. FDOJ cohorts showed a 30-fold mean overexpression of RANTES and a 20-fold overexpressed level of FGF-2 when compared to healthy controls. As RANTES is discussed in the literature as a possible contributor to inflammatory diseases, we hypothesize that FDOJ in areas of improper and incomplete wound healing in the jawbone may hyperactivate signaling pathways. Constituting a hidden source of silent inflammation FDOJ may represent a hitherto unknown cause for the development of CFS.
Asunto(s)
Quimiocina CCL5/biosíntesis , Síndrome de Fatiga Crónica/metabolismo , Enfermedades Maxilomandibulares/metabolismo , Maxilares/metabolismo , Osteonecrosis/metabolismo , Adulto , Anciano , Síndrome de Fatiga Crónica/patología , Femenino , Factor 2 de Crecimiento de Fibroblastos/biosíntesis , Humanos , Maxilares/patología , Enfermedades Maxilomandibulares/patología , Masculino , Persona de Mediana Edad , Osteonecrosis/patologíaRESUMEN
Bacterial infections of the residual dentin or infected pulp tissue are responsible for most cases of endodontic treatment failures. Persisting microorganisms in necrotic pulp tissue produce sulphur components such as methyl mercaptan and hydrogen sulfide as well as thioether derivatives. Although there is emerging evidence that these sulphur compounds stimulate immune cells and induce the inflammatory cascade, the immunological mechanisms of local and systemic inflammation have not been described. In this retrospective study we evaluated the ex-vivo immune response of peripheral blood mononuclear cells to sulphur compounds in 53 patients with clinical or radiologic endodontic treatment failure, 20 patients with clinical discomfort or radiological findings without previous endodontic treatment and a control group of 31 patients who had received successful endodontic treatment at least five years previously. Patients with endodontic abnormalities showed significantly higher ex-vivo sulphur compound-stimulated interferon-gamma (IFN-γ) and interleukin-10 (IL-10) levels as compared to the control group. The association between ex-vivo-stimulated cytokines and endodontically derived sulphur compounds was further substantiated by the fact that the number of IFN-γ and/or IL-10-positive patients decreased significantly 3-8 months after re-treatment of the root canal or tooth extraction. Furthermore, serum tumor necrosis factor-alpha (TNF-α) levels were higher in patients than in controls, and at the same time, the TNFA -308 G/A polymorphism was associated with endodontic treatment failure in our study population. We conclude that a cellular immune response to sulphur compounds contributes to the inflammatory process observed in relation to endodontic treatment failures.
Asunto(s)
Citocinas/sangre , Necrosis de la Pulpa Dental/inmunología , Sulfuro de Hidrógeno/farmacología , Leucocitos Mononucleares/efectos de los fármacos , Compuestos de Sulfhidrilo/farmacología , Diente no Vital/sangre , Factor de Necrosis Tumoral alfa/genética , Adulto , Anciano , Estudios de Casos y Controles , Citocinas/metabolismo , Necrosis de la Pulpa Dental/metabolismo , Femenino , Humanos , Interferón gamma/sangre , Interleucina-10/sangre , Leucocitos Mononucleares/metabolismo , Masculino , Persona de Mediana Edad , Polimorfismo Genético , Tratamiento del Conducto Radicular , Diente no Vital/inmunología , Insuficiencia del Tratamiento , Factor de Necrosis Tumoral alfa/sangre , Adulto JovenRESUMEN
The sequence of the human leukocyte antigen (HLA)-DRB1*1475 differs from the closest aligned sequence HLA-DRB1*140102 by a single-nucleotide substitution at codon 81 (CAC-->TAC) resulting in an amino acid change from Leu to Gln.
Asunto(s)
Antígenos HLA-DR/genética , Alelos , Sustitución de Aminoácidos , Secuencia de Bases , Femenino , Cadenas HLA-DRB1 , Humanos , Datos de Secuencia Molecular , Alineación de SecuenciaRESUMEN
BACKGROUND: Specific immunotherapy (SIT) is believed to modulate CD4+ T-helper cells. In order to improve safety, SIT vaccines are often formulated with allergoids (chemically modified allergens). Interaction between T-cells and allergoids is necessary to influence cellular cytokine expression. There have been few reports on identification the early cellular effects of SIT. METHOD: Patients allergic to grass and/or mugwort pollen (n= 21) were treated with a 4-shot allergy vaccine (Pollinex Quattro) containing appropriate allergoids (grass/rye and/or mugwort) adsorbed to L-tyrosine plus a Th1 adjuvant, monophosphoryl lipid A (MPL). Fourteen grass-allergic patients served as untreated controls. Using the peripheral blood mononuclear cells of these patients, an optimized lymphocyte transformation test (LTT) was employed to monitor the in vitro proliferative response of T-cells to an allergoid challenge (solubilised Pollinex Quattro) before the first and last injection and then 2 and 20 weeks after the final injection. Control challenges utilised preparations of a similar pollen vaccine without the adjuvant MPL and a tree pollen vaccine with and without MPL. RESULTS: The LTT showed increased LTT stimulation indices (SI) in 17/20 SIT patients when the solublised vaccine preparation was used as a challenge before the last injection and 2 weeks after, in comparison to pre-treatment levels. Twenty weeks after therapy, the SI decreased to baseline level. A vaccine challenge without MPL gave lower SI levels. A challenge of a clinically inappropriate tree allergoid vaccine gave no response, and a nontreated group also showed no response. CONCLUSION: Following a short-course SIT adjuvated with MPL, challenges of allergoids were shown to activate allergen-specific T cells in vitro. There was an additional stimulating effect when the challenge was in combination with MPL. There were no non-specific effects of MPL, shown by the tree allergoid/MPL control. The timing of the response was closely correlated to the treatment course; reactivity fell two weeks after the final injection and 20 weeks later it was at baseline level. Thus an immunological response to SIT was detected after very few injections. This methodology could provide a basis for monitoring the immediate progress of allergy vaccinations.
Asunto(s)
Hipersensibilidad/terapia , Inmunoterapia , Extractos Vegetales/administración & dosificación , Linfocitos T/inmunología , Vacunas/administración & dosificación , Adyuvantes Inmunológicos/administración & dosificación , Adolescente , Adulto , Alérgenos/administración & dosificación , Alérgenos/inmunología , Alergoides , Artemisia/inmunología , Femenino , Humanos , Hipersensibilidad/inmunología , Lípido A/administración & dosificación , Lípido A/análogos & derivados , Masculino , Persona de Mediana Edad , Extractos Vegetales/inmunología , Poaceae/inmunología , Secale/inmunología , Células TH1/inmunología , Tirosina/químicaRESUMEN
The measurement of the proliferative response of primed T cells to an antigenic stimulus (lymphocyte transformation assay: LTT) is commonly used for determining T cell immune responsiveness. However, the ratio between the spontaneous and the antigen-triggered response (stimulation index) is frequently quite low (<3-5) making the interpretation difficult. We modified the assay by the addition of interferon-alpha and the use of fresh autologous serum instead of human AB pool serum. These measures significantly enhanced the stimulation index following stimulation with tetanus toxoid, Candida albicans and tick-borne encephalitis (TBE) viral antigen in studies of sensitized patients. There was no concomitant increase in false positive results. Kinetic studies showed a reduced nonspecific background proliferation of non-stimulated cultures particularly between days 4 and 6 of culture. Furthermore, the positive effect of interferon-alpha were confirmed in studies of patients with contact allergy to nickel and gold. We conclude that this modified form of proliferation assay significantly increases the signal to noise ratio which can be attained. This may be of particular value when looking at T cell responses in immunocompromised patients or in diagnostic attempts to detect very low frequencies of antigen-specific T cells.
Asunto(s)
Antígenos , Activación de Linfocitos , Linfocitos T/inmunología , Adulto , Antígenos/administración & dosificación , Antígenos Fúngicos/administración & dosificación , Antígenos Virales/administración & dosificación , Candida albicans/inmunología , Virus de la Encefalitis Transmitidos por Garrapatas/inmunología , Femenino , Humanos , Técnicas In Vitro , Interferón alfa-2 , Interferón-alfa/administración & dosificación , Cinética , Masculino , Persona de Mediana Edad , Proteínas Recombinantes , Toxoide Tetánico/administración & dosificaciónRESUMEN
BACKGROUND: In patients with alcoholic liver cirrhosis, endotoxaemia is a frequent finding. Unknown mechanisms, however, prevent typical clinical symptoms of endotoxaemia in many patients. METHODS: We determined plasma levels of pro- and anti-inflammatory mediators, ex vivo cytokine secretion capacity, and expression of tumour necrosis factor (TNF) receptors on phagocytic blood cells in 49 patients with alcoholic cirrhosis and 41 age matched healthy controls. RESULTS: In addition to increased levels of proinflammatory cytokines in cirrhotic patients, we observed consistent upregulation of the anti-inflammatory mediators interleukin 10 (IL-10) (plasma 15.75 (1. 6) v 6.6 (1.3) pg/ml (p<0.001); ex-vivo 108.4 (22.0) v 40.1 (7.4) pg/ml (p<0.05)), interleukin 1 receptor antagonist (plasma 527.1 (83) v 331.4 (56) pg/ml (p<0.05); ex vivo 19.9 (3.4) v 10.2 (2.7) ng/ml (p<0.01)), and soluble TNF receptors (sTNF-R) in plasma (sTNF-RI 3157.2 (506.2) v 607.9 (300.3) pg/ml; sTNF-RII 3331.0 (506. 2) v 1066.4 (225.1) pg/ml (p<0.001 for both)). Desensitisation at the target cell level was indicated by reduced expression of TNF receptor I on granulocytes (64.8 (6.5) v 40.1 (7.3)% positive cells; p<0.05) and unaltered plasma levels of soluble E-selectin. CONCLUSION: In patients with alcoholic liver cirrhosis, upregulation of the pro- and anti-inflammatory cytokine system and simultaneous desensitisation of effector cells could explain the restricted systemic inflammatory response to chronic endotoxaemia. This alteration in immune status may lead to impairment of host defences against infections which are frequent complications of alcoholic cirrhosis.
Asunto(s)
Endotoxinas/inmunología , Tolerancia Inmunológica , Interleucina-10/inmunología , Cirrosis Hepática Alcohólica/inmunología , Receptores de Interleucina-1/inmunología , Receptores del Factor de Necrosis Tumoral/inmunología , Adulto , Estudios de Casos y Controles , Femenino , Granulocitos/inmunología , Humanos , Interleucina-10/sangre , Cirrosis Hepática Alcohólica/sangre , Masculino , Persona de Mediana Edad , Receptores de Interleucina-1/antagonistas & inhibidores , Receptores de Interleucina-1/sangre , Receptores del Factor de Necrosis Tumoral/sangre , Linfocitos T Reguladores/inmunología , Regulación hacia ArribaRESUMEN
Endotoxin tolerance (ET) has been described as a temporary alteration in the lipopolysaccharide (LPS) response of monocytic cells after an initial LPS exposure with respect to the production of soluble immunomodulators. Apart from the LPS response, monocytic cells play an important role in initiation of the specific immune response as antigen-presenting cells. This study investigated the capacity of human blood monocytes to induce T-cell stimulation in ET. First, the expression of monocyte surface molecules, important for T-cell interaction, was analyzed by flow cytometry. In vitro priming of peripheral blood mononuclear cells with LPS clearly down-regulates major histocompatibility complex class II molecules and the costimulatory molecule CD86. Both changes were dependent on the endogenous interleukin (IL)-10 and less so on the transforming growth factor-beta. In contrast, other accessory molecules on monocytes were only marginally down-regulated (CD58), were not significantly changed during ET (CD40), or even remained up-regulated after initial LPS priming (CD54, CD80). Second, an impact of these phenotypic alterations on the accessory function of monocytes was observed. This was manifested as diminished T-cell proliferation and interferon (IFN)-gamma release in response to the presence of different recall antigens. Neutralizing IL-10 during LPS priming prevented the diminished T-cell IFN-gamma production but had little effect on T-cell proliferation. These data confirm that ET is an appropriate model of the monocyte functional state in immunoparalysis, which is frequently observed in patients after septic shock, trauma, or major surgery.
Asunto(s)
Lipopolisacáridos/farmacología , Monocitos/inmunología , Linfocitos T/inmunología , Antígenos CD/sangre , Antígenos CD/genética , Células Cultivadas , Escherichia coli , Antígenos HLA-DR/sangre , Antígenos HLA-DR/genética , Humanos , Interferón gamma/biosíntesis , Activación de Linfocitos , Monocitos/efectos de los fármacos , Factor de Necrosis Tumoral alfa/biosíntesisRESUMEN
The function of small GTPases is fine-tuned by a complex network of regulatory proteins such as GTPase-activating proteins. The C1 gene at Xq28 encodes a protein assumed to function as a Rho GTPase-activating protein (rhoGAP). Characterization of the molecular defect causing X-linked nephrogenic diabetes insipidus (NDI) in a patient revealed a submicroscopic deletion of a 21.5-kb genomic fragment encompassing the entire arginine-vasopressin V2 receptor gene (AVPR2) and most of the C1 gene locus. In the absence of detailed information about the physiological relevance and specific functions of rhoGAP C1, a thorough clinical and laboratory investigation of the patient was performed. Besides clearly defined NDI symptoms caused by deletion of the AVPR2 gene, no major morphological abnormalities as determined by physical examination, radiography, ultrasound, and computed tomographic scan were detected. Extensive analysis of blood chemical, enzyme, and hormone values over a period of 16 years showed no deviations from normal ranges. On the basis of our observations, the rhoGAP C1 protein is not essential for normal development in the human. Because of a predominant expression pattern of the C1 gene in hematopoietic cells, we focused on immunologic and hematologic laboratory parameters of the affected boy and the mother who was found to be heterozygous. Differential white cell counts, including lymphocyte typing, determination of lymphokines, cytokines, and immunoglobulins, as well as numerous leukocyte function tests, showed no pathological findings. Therefore, we postulate that the loss of rhoGAP C1 function is most likely compensated by other members of the GAP family.
Asunto(s)
Diabetes Insípida Nefrogénica/genética , Proteínas de Unión al GTP/genética , Proteínas Activadoras de GTPasa , Eliminación de Gen , Receptores de Vasopresinas/genética , Adolescente , Envejecimiento/sangre , Recuento de Células Sanguíneas , Análisis Mutacional de ADN , Diabetes Insípida Nefrogénica/sangre , Sistema Hematopoyético/metabolismo , Humanos , Inmunofenotipificación , Leucocitos/inmunología , Leucocitos/metabolismo , Masculino , Fenotipo , Reacción en Cadena de la Polimerasa , Eliminación de Secuencia , Cromosoma X/genéticaRESUMEN
A large number of compounds are known to reduce the ATP-dependent efflux pump activity of multidrug resistant (mdr) tumor cells. Here we report that an infection of cancer cells with T. gondii reduced the multidrug resistance of the tumour cells against cytostatic drugs. Two mouse lymphoma cell lines (Mdr L 5718 and Par 5718) were infected with Toxoplasma gondii in vitro and the reduction of efflux pump activity of the cells was measured. The drug accumulation (Rhodamin-123) was increased in the infected mdr cell lines compared with non- infected mdr-cells, and no effect was shown after infection of the parental cell line. The same effect was also achieved by incubation of Mdr-tumor cells with cell lysate of Toxoplasma gondii. Mdr-1-gene expression was reduced in the infected cell lines 48 hours after infection. Co-cultivation of Toxoplasma gondii with mdr cell lines separated by a microfilter from tumor cells was performed, but this cocultivation did not change the mdr efflux activity. The effect of Toxoplasma gondii infection on the efflux pump activity and mdr-1 gene expression was also examined in the human gastric cancer cells. A sensitization of resistant gastric cancer cells was also achieved by parasite infection. This phenomenon is an evidence that a reduction of resistance in tumor cells can be achieved by a natural parasite infection. It is as yet unclear whether an active infection or another substance of T. gondii is responsible for this phenomenon.
Asunto(s)
Resistencia a Múltiples Medicamentos , Resistencia a Antineoplásicos , Linfoma/tratamiento farmacológico , Neoplasias Gástricas/tratamiento farmacológico , Toxoplasma/fisiología , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/genética , Animales , Humanos , Linfoma/parasitología , Ratones , Neoplasias Gástricas/parasitología , Células Tumorales Cultivadas , Vacuolas/fisiologíaRESUMEN
Immunoparalysis is an acquired immunodeficiency which may occur in patients after major surgery, burns, polytrauma and sepsis. It is associated with a modified state of monocytes marked by their altered capacity to induce antigen-specific T cell stimulation and to release various cytokines. However, the pathogenesis of immunoparalysis may differ in various patient groups. It can develop in patients after systemic hyperinflammation induced by gastrointestinal translocation of endotoxin (lipopolysaccharide, LPS) or sepsis, as well as in patients without preceding systemic inflammation but primary anti-inflammation, for instance induced by sympathetic activation. To further elucidate the syndrome, we compared endotoxin tolerance as a model of immunoparalysis after systemic hyperinflammation versus interleukin-10 (IL-10) treatment as a model of primarily anti-inflammation-induced immunoparalysis. In vitro priming of peripheral blood mononuclear cells with either LPS or IL-10 for 24 h led to a strongly or moderately diminished LPS-induced tumor necrosis factor-alpha (TNF-alpha) production, compared to unprimed controls, respectively. Furthermore, LPS-induced reduction of TNF-alpha production capacity persisted over the following days whereas IL-10-primed monocytes rapidly recovered. Similarly, in contrast to persistently diminished MHC class II expression in LPS-treated monocytes, IL-10 only transiently downregulated these molecules. Consequently, in contrast to IL-10-primed monocytes, LPS-primed monocytes were greatly impaired in their capacity to induce antigen-specific T cell proliferation and IFN-gamma production. These data indicate that LPS priming provokes a more profound modulation of monocyte function than IL-10 priming, raising the question of possible variations in the clinical course of immunoparalysis, dependent on its pathogenesis.